If your business is focused on creating innovative treatments for visual system diseases, this program is tailor-made for you. You have the chance to transform your lab research into effective therapies that can benefit clinicians and patients alike. The primary goal is to help you generate crucial preclinical data, paving the way for applications to the FDA. This means real potential for your research to make a difference in the medical field.

There is no funding cap, offering flexibility to ensure your specific needs are met. Whether you’re a small startup or an established company, the opportunities are vast. By joining this program, you will gain support to advance a single therapeutic candidate through essential studies. You’ll also receive guidance on outlining the steps needed to prepare for clinical trials, bringing your innovative ideas closer to reality. This program turns your groundbreaking research into tangible outcomes that can improve lives.

The financing offered through this program is a grant. This means you don’t have to pay it back, making it a great opportunity for your business to access funds without the worry of loans.

Repayment Terms and Interest Rates

• No repayment required. Since this is a grant, you won’t deal with repayment terms or interest rates. Once you receive the funds, they are yours to use as outlined by the program guidelines.

Eligible Expenses

You can use these funds for a variety of expenses related to developing innovative therapies or devices. Here are the key areas covered:

• Research and development costs
• Preclinical data generation
• Clinical trial design
• Regulatory submission expenses, specifically for the IND and IDE applications

Restrictions and Fees

• What the funds cannot be used for: You cannot use the grant funds for general business operations, personal expenses, or projects that do not align with the goals of translating innovative research into therapeutic solutions.
• Fees: There are no hidden fees associated with the grant. It’s straightforward – apply, receive funding, and utilize it according to the program requirements without unexpected costs.

This program is designed to help transform your innovative lab research into effective treatments for visual system diseases. If your business is involved in creating biological, pharmacological, or medical device interventions, this is a valuable opportunity. The focus is on generating preclinical data that can lead to applications for Investigational New Drug (IND) or Investigational Device Exception (IDE) with the FDA.

With this funding, you can advance a single therapeutic candidate through critical studies. The program helps you clearly outline the steps necessary to develop your product, which can lead to real-world clinical trials. The intention is to make new therapies available to clinicians and their patients as quickly as possible.

There is no set limit on the funding amount, so your business has the potential to receive the resources it needs to grow. This program supports a wide range of businesses, regardless of size or revenue. It's a chance to turn groundbreaking research into actual treatments that can improve lives.